• Sectors we work in banner(2)

    Quick Reads

The ongoing fight against fakes

When counterfeit goods are mentioned, initial thoughts may be of luxury items such as handbags copied in a far cheaper and more accessible form. Hidden behind such goods is the harm done to rights holders, who have invested time and money developing and producing a product, and the organised crime and downstream harm caused by such counterfeit items. However, other products are also counterfeited and the impact to the consumer can be more immediate and dangerous – electrical goods and pharmaceuticals are two categories that are also frequently copied.

EUROPOL recently coordinated the fourth edition of Operation SHIELD, a global effort to tackle fake pharmaceuticals.  The operation saw 1,284 individuals charged and took fake medicines worth EUR 64 million off EU markets.

The sale of fake pharmaceuticals, and illegal trafficking of pharmaceuticals, continues to be a growing issue and is a significant public health problem.

The Internet remains an enticing outlet for suppliers of counterfeit goods and social media is a current popular forum for selling counterfeit and illegally sold medicines. Of key importance is educating users of social media, particularly younger generations, on the significant safety risks associated with sourcing pharmaceuticals outside the legitimate supply chain. As consumers, it is key that we question what the item is and where it has come from.

Brand owners should seek to protect and enforce their trade mark rights to help curb the proliferation of counterfeit products worldwide and protect consumers. 

The EUROPOL press release makes for impressive reading but the fight against counterfeiters is ongoing. Vigilance by consumers and brand owners, and protection of important intellectual property, are key.

 

Medicines are often counterfeited in underground laboratories without any regulation or safety measures in place. Counterfeit products created under such circumstances do not produce the desired effect; in the best case scenario the patient remains untreated, however such products can cause serious health issues or be potentially lethal.

Our thinking

  • IBA Annual Conference 2025

    Simon Ridpath

    Events

  • New homes - 1.5m Target

    Tegan Johnson

    Insights

  • Hanh Nguyen, Hannah Edwards and Francesca Heath-Clarke contribute to the Legal Q&A section of R3 RECOVERY Magazine

    Hanh Nguyen

    In the Press

  • International Adviser quotes Dominic Lawrance on speculation that the UK is considering softening IHT rules on non-doms’ global assets

    Dominic Lawrance

    In the Press

  • Caroline Greenwell recognised in GIR’s ‘Women in Investigations 2025’ list

    Caroline Greenwell

    News

  • FCA Supercharged Sandbox, Encouraging AI Experimentation With NVIDIA

    Charlotte Hill

    Insights

  • Navigating supply chain disputes and risk

    Melanie Tomlin

    Insights

  • Charles Russell Speechlys advises the majority sellers of Portas Consulting on the sale of the company to a division of Creative Artists Agency

    Keir Gordon

    News

  • Charles Russell Speechlys’ ‘Russell Up’ initiative wins at The Lawyer Awards 2025

    Joe Cohen

    In the Press

  • When Artificial 'Intelligence' invents Artificial Cases - how to navigate AI use in civil law proceedings?

    Charlotte Posnansky

    Quick Reads

  • Arbitration for family offices

    Tamasin Perkins

    Insights

  • Behind the Curtain: Enforcing Contracts as an Undisclosed Principal in English Law

    Gareth Mills

    Insights

  • Reforms to the UK tax treatment of carried interest

    Alice Wilne

    Insights

  • Retail Collection – Episode 4: Caffé Nero – lessons from a life in retail management

    Michael Powner

    Podcasts

  • Nuptial Agreements: Perspectives from England and Hong Kong

    Sarah Higgins

    Insights

  • Beyond Gateway 2

    Mark Barley

    Insights

  • Business Assets in an English Divorce – How Can Parties Protect their Interests?

    Sarah Jane Boon

    Insights

  • Triple Play "Bid Fever": UK Tech's ability to scale and go global

    Mark Howard

    Quick Reads

  • The Future of AI and Copyright Regulation in the UK: The Data (Use and Access) Bill finally gets Lords approval in the UK

    Rebecca Steer

    Quick Reads

  • HM Land Registry's Digital Drive - Delays Persist but perhaps there is light at the end of the tunnel?

    Maisy-Jane Cook

    Quick Reads

Back to top